Share Price, page-11413

There are plenty of hypothesis why on this thread if you choose to read them. You have to actually critically think for yourself. There is no real answer.

Some think $25 was overshot and we deserve to come back but have gone too far. Some (dicks in my view) think we’re graded to $10 - with no basis if you don’t mind. Some think we should be $20. Some think market manipulation either because they can or because we’re being softened for a low ball bid. Some think that the Australian market has fk all understanding of biotech value because we don’t dig anything out of the ground (I’m in that camp, plus the manipulation because they can camp)

I have stated my view - you can choose yours.

My valuation is roughly $1.5 billion for Trofenitide based on 15% of $348 million UsD sales at 1.5 exchange rate x 20 multiplier - equals $1.5 billion

Add 3 x Daybue value x 30% chance of success which is very conservative in my view - I’d be happy to go to 70% but for the purpose of this discussion use 30% - equals $1.5 billion total $3 billion divide by 140 million shares on issue gives $22

Whats your number?

Shiw some inkling of knowledge